Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.5 USD | -1.51% | -6.08% | -0.04% |
05-06 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |
05-06 | Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.04% | 2.64B | |
+27.63% | 48.16B | |
-0.71% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.80% | 25.59B | |
-22.65% | 18.96B | |
+8.03% | 12.92B | |
+29.84% | 12.03B | |
-2.20% | 11.77B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Celldex Therapeutics : Cantor Fitzgerald Adjusts Celldex Therapeutics PT to $35 From $22, Maintains Overweight Rating